Duke researchers utilize gene editing to improve cancer drugs’ performance
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and biomaterials science to improve the efficacy, accuracy and longevity of certain cancer therapies.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed